These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18536625)

  • 1. [Inhaled corticosteroids in asthma: a medico-economic analysis of clinical trials].
    Vergnenègre A; Godard P; Atsou K; Chouaïd C
    Rev Mal Respir; 2008 Apr; 25(4):375-89. PubMed ID: 18536625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FourFold Asthma Study (FAST): a study protocol for a randomised controlled trial evaluating the clinical cost-effectiveness of temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations.
    Skeggs A; McKeever T; Duley L; Mitchell E; Bradshaw L; Mortimer K; Walker S; Parrott S; Wilson A; Pavord I; Brightling C; Thomas M; Price D; Devereux G; Higgins B; Harrison T; Haydock R
    Trials; 2016 Oct; 17(1):499. PubMed ID: 27737713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of asthma controller medications on clinical, economic, and patient-reported outcomes.
    Tan H; Sarawate C; Singer J; Elward K; Cohen RI; Smart BA; Busk MF; Lustig J; O'Brien JD; Schatz M
    Mayo Clin Proc; 2009 Aug; 84(8):675-84. PubMed ID: 19648384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-utility analysis of once-daily versus twice-daily inhaled corticosteroid dosing for maintenance treatment of asthma in pediatric patients.
    Rodriguez-Martinez CE; Sossa-Briceño MP; Castro-Rodriguez JA
    J Asthma; 2016 Jun; 53(5):538-45. PubMed ID: 26786524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice.
    Goossens LM; Riemersma RA; Postma DS; van der Molen T; Rutten-van Mölken MP
    Adv Ther; 2009 Sep; 26(9):872-85. PubMed ID: 19768640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of generic-only drug benefits on patients' use of inhaled corticosteroids in a Medicare population with asthma.
    Fung V; Tager IB; Brand R; Newhouse JP; Hsu J
    BMC Health Serv Res; 2008 Jul; 8():151. PubMed ID: 18638405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model.
    Paltiel AD; Fuhlbrigge AL; Kitch BT; Liljas B; Weiss ST; Neumann PJ; Kuntz KM
    J Allergy Clin Immunol; 2001 Jul; 108(1):39-46. PubMed ID: 11447380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes and cost benefits associated with the introduction of inhaled corticosteroid therapy in a medicaid population of asthmatic patients.
    Balkrishnan R; Norwood GJ; Anderson A
    Clin Ther; 1998; 20(3):567-80. PubMed ID: 9663371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
    O'Connor RD; Stanford R; Crim C; Yancey SW; Edwards L; Rickard KA; Dorinsky P
    Ann Allergy Asthma Immunol; 2004 Dec; 93(6):581-8. PubMed ID: 15609769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting UK primary-care costs of managing patients with asthma over 5 years.
    Dasgupta R; Guest JF
    Pharmacoeconomics; 2003; 21(5):357-69. PubMed ID: 12627989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-utility analysis of the inhaled steroids available in a developing country for the management of pediatric patients with persistent asthma.
    Rodríguez-Martínez CE; Sossa-Briceño MP; Castro-Rodriguez JA
    J Asthma; 2013 May; 50(4):410-8. PubMed ID: 23356720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particle size of inhaled corticosteroids: does it matter?
    Leach C; Colice GL; Luskin A
    J Allergy Clin Immunol; 2009 Dec; 124(6 Suppl):S88-93. PubMed ID: 19962042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma.
    Edmonds ML; Camargo CA; Pollack CV; Rowe BH
    Cochrane Database Syst Rev; 2003; (3):CD002308. PubMed ID: 12917930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomic test that predicts response to inhaled corticosteroids in adults with asthma likely to be cost-saving.
    Wu AC; Gay C; Rett MD; Stout N; Weiss ST; Fuhlbrigge AL
    Pharmacogenomics; 2015; 16(6):591-600. PubMed ID: 25880024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
    Ni CM; Greenstone IR; Ducharme FM
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-benefit impact of free asthma medication provision for the pediatric population.
    Koltermann V; Friedrich FO; Fensterseifer AC; Ongaratto R; Pinto LA
    Respir Med; 2020 Apr; 164():105915. PubMed ID: 32217290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma.
    Lyseng-Williamson KA; Plosker GL
    Pharmacoeconomics; 2003; 21(13):951-89. PubMed ID: 12959627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cost effectiveness of treatment with salmeterol/fluticasone compared to montelukast for the control of persistent asthma in children].
    Rely K; McQuire SE; Alexandre PK; Escudero GS
    Value Health; 2011; 14(5 Suppl 1):S43-7. PubMed ID: 21839898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cost-effectiveness analysis of first-line controller therapies for persistent asthma.
    Shih YC; Mauskopf J; Borker R
    Pharmacoeconomics; 2007; 25(7):577-90. PubMed ID: 17610338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis.
    Sobieraj DM; Weeda ER; Nguyen E; Coleman CI; White CM; Lazarus SC; Blake KV; Lang JE; Baker WL
    JAMA; 2018 Apr; 319(14):1485-1496. PubMed ID: 29554195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.